Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

25,407 signal articles · 199 in last 24h · 121,335 total before filter · latest 20m ago
199last 24h
1287last 7d
222● bullish (7d)
147● bearish (7d)
205publishers
AllMacro225Earnings437M&A101Regulatory22Product9Analyst15
✕ clear all filterssentiment: bullishSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Honeywell upgraded by Bank of America on stronger order trends
Proactive23d agobullish
Honeywell upgraded by Bank of America on stronger order trends

Honeywell International Inc (NYSE:HON, XETRA:ALD) was upgraded to ‘Neutral’ from ‘Underperform’ by Bank of America, which raised its price objective to $265 from $220, above current levels of $247, following a second quarter performance that exceeded expectations and improved visibility into the...

Apple Upgrade program seen as "directionally positive" by BofA
Proactive23d agobullish
Apple Upgrade program seen as "directionally positive" by BofA

Apple Inc (NASDAQ:AAPL, XETRA:APC) has rolled out Apple Upgrade nationwide in the US, a hardware-leasing program available through the company's online store, the Apple Store app and its retail locations. The program offers 12- and 24-month leasing terms for iPhone and Apple Watch, and 24-...

More Americans admit to shoplifting from Walmart as inflation climbs
TheStreet23d agobullish
More Americans admit to shoplifting from Walmart as inflation climbs

Nearly a third of Americans say they have shoplifted at some point in their lives, according to a new LendingTree survey — a figure that has climbed as high prices for groceries, housing and insurance continue to strain household budgets. The survey found that 30% of respondents admitted to ...

Botox Maker Tops Buy Point, But Here Comes The Earnings Report
Investor's Business Daily23d agobullish
Botox Maker Tops Buy Point, But Here Comes The Earnings Report

AbbVie closed above the 230.47 buy point from a cup-with-handle base on June 23 and has climbed 15% from there. The previous day, the stock jumped more than 6% after AbbVie announced it agreed to acquire Apogee Therapeutics. The $10.9 billion deal would strengthen AbbVie's immunology pipeline.

How Teradyne’s (TER) AI Test Push and Tokyo Electron Partnership Could Reshape Investor Expectations
Simply Wall St.23d agobullish
How Teradyne’s (TER) AI Test Push and Tokyo Electron Partnership Could Reshape Investor Expectations

Teradyne, Inc. recently announced it would report its Q2 2026 results on July 28 at 4:30 p.m. US Eastern Time, following a period of strong year-on-year revenue growth and improved inventory levels. Investor focus is now on how Teradyne’s growing AI-related revenue, new AI chip test solutions, and partnership with Tokyo Electron might shape expectations for its semiconductor test and robotics businesses. We’ll now examine how anticipation of AI-driven revenue strength ahead of this earnings...